These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3500589)

  • 1. Disease modifying activity of HWA 486 in rat adjuvant-induced arthritis.
    Pasternak RD; Wadopian NS; Wright RN; Siminoff P; Gylys JA; Buyniski JP
    Agents Actions; 1987 Aug; 21(3-4):241-3. PubMed ID: 3500589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunopharmacological profile of a novel isoxazol derivative, HWA 486, with potential antirheumatic activity--I. Disease modifying action on adjuvant arthritis of the rat.
    Bartlett RR; Schleyerbach R
    Int J Immunopharmacol; 1985; 7(1):7-18. PubMed ID: 3873420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunopharmacological profile of HWA 486, a novel isoxazol derivative--II. In vivo immunomodulating effects differ from those of cyclophosphamide, prednisolone, or cyclosporin A.
    Bartlett RR
    Int J Immunopharmacol; 1986; 8(2):199-204. PubMed ID: 3486841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug actions on delayed-type hypersensitivity in rats with developing and established adjuvant arthritis.
    Hambleton P; McMahon S
    Agents Actions; 1990 Mar; 29(3-4):328-32. PubMed ID: 2339672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leflunomide (HWA 486) inhibits experimental autoimmune tubulointerstitial nephritis in rats.
    Thoenes GH; Sitter T; Langer KH; Bartlett RR; Schleyerbach R
    Int J Immunopharmacol; 1989; 11(8):921-9. PubMed ID: 2613396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomodulating effects of T-44 in comparison to HWA 486.
    Schmidt K; Bekemeier H; Giessler J; Pilopp H
    Agents Actions; 1991 Jan; 32(1-2):114-6. PubMed ID: 2058457
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of anti-arthritic properties of leflunomide with methotrexate and FK506: effect on T cell activation-induced inflammatory cytokine production in vitro and rat adjuvant-induced arthritis.
    Magari K; Miyata S; Nishigaki F; Ohkubo Y; Mutoh S
    Inflamm Res; 2004 Oct; 53(10):544-50. PubMed ID: 15597149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thalidomide analogue CC1069 inhibits development of rat adjuvant arthritis.
    Oliver SJ; Freeman SL; Corral LG; Ocampo CJ; Kaplan G
    Clin Exp Immunol; 1999 Nov; 118(2):315-21. PubMed ID: 10540197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of FTY720, a novel immunosuppressant, on adjuvant-induced arthritis in rats.
    Matsuura M; Imayoshi T; Chiba K; Okumoto T
    Inflamm Res; 2000 Aug; 49(8):404-10. PubMed ID: 11028757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical delivery of leflunomide for rheumatoid arthritis treatment: evaluation of local tissue deposition of teriflunomide and its anti-inflammatory effects in an arthritis rat model.
    Bae J; Park JW
    Drug Dev Ind Pharm; 2016; 42(2):254-62. PubMed ID: 26006334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppressive effect of an orally active MEK1/2 inhibitor in two different animal models for rheumatoid arthritis: a comparison with leflunomide.
    Yamaguchi T; Kakefuda R; Tanimoto A; Watanabe Y; Tajima N
    Inflamm Res; 2012 May; 61(5):445-54. PubMed ID: 22245957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of leflunomide (HWA 486) on expression of lymphocyte activation markers.
    Zielinski T; Müller HJ; Bartlett RR
    Agents Actions; 1993; 38 Spec No():C80-2. PubMed ID: 8317329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NO-naproxen modulates inflammation, nociception and downregulates T cell response in rat Freund's adjuvant arthritis.
    Cicala C; Ianaro A; Fiorucci S; Calignano A; Bucci M; Gerli R; Santucci L; Wallace JL; Cirino G
    Br J Pharmacol; 2000 Jul; 130(6):1399-405. PubMed ID: 10903982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin 6 inhibits delayed-type hypersensitivity and the development of adjuvant arthritis.
    Mihara M; Ikuta M; Koishihara Y; Ohsugi Y
    Eur J Immunol; 1991 Oct; 21(10):2327-31. PubMed ID: 1915548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of collagen-induced arthritis by an angiogenesis inhibitor, AGM-1470, in combination with cyclosporin: reduction of vascular endothelial growth factor (VEGF).
    Oliver SJ; Cheng TP; Banquerigo ML; Brahn E
    Cell Immunol; 1995 Dec; 166(2):196-206. PubMed ID: 7497521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of immunostimulatory ribomunyl on the preventive treatment of rat adjuvant arthritis with cyclosporine and methotrexate.
    Rovensky J; Svík K; Stancíková M; Istok R
    J Rheumatol; 2003 Sep; 30(9):2027-32. PubMed ID: 12966611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lymphocyte subpopulations in adjuvant arthritis of rats. Effects of corticoids and gamma irradiation].
    Piatier D; Kahan A; Le Gô A; Delbarre F
    C R Acad Hebd Seances Acad Sci D; 1978 May; 286(18):1327-30. PubMed ID: 96995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunomodulating activity of Wy-41,770 (5H-dibenzo[A,D]cyclohepten-5-ylidene) acetic acid.
    Carlson RP; Datko LJ; O'Neill-Davis L; Lewis AJ
    J Immunopharmacol; 1986; 8(2):205-21. PubMed ID: 3487593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of multiple treatments of isoxicam on organ weights and serum SGPT, AP, and BUN in adjuvant-induced polyarthritic rats.
    DiPasquale G; Rassaert C; Welaj P; Gingold J; Schwartz E
    Res Commun Chem Pathol Pharmacol; 1978 Mar; 19(3):529-32. PubMed ID: 653106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anti-arthritic and immunosuppressive effects of cyclosporine on arthritis induced in the rat by type II collagen.
    Henderson B; Staines NA; Burrai I; Cox JH
    Clin Exp Immunol; 1984 Jul; 57(1):51-6. PubMed ID: 6744674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.